Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential
暂无分享,去创建一个
James B. Munro | Zalak V. Shah | Joana C. Silva | S. Koren | A. Phillippy | S. Hoffman | C. Fraser | J. Crabtree | L. Tallon | J. Hotopp | R. Sauerwein | D. Saunders | Chanthap Lon | M. Nyunt | C. Plowe | S. Takala-Harrison | E. Drábek | Lisa Sadzewicz | Julie C. Dunning Hotopp | K. Lyke | B. Sim | M. Travassos | M. Laufer | E. Stucke | A. Dwivedi | Z. Shah | Tao Li | M. Adams | K. Moser | Michele D Spring | K. Jongsakul | M. U. Ferreira | A. Dara | A. Ouattara | C. Lon | P. T. Rodrigues | Amed Ouattara | Ankit Dwivedi | Shannon Takala-Harrison | Zalak Shah | B. Sparklin | L. Sadzewicz | Emily M. Stucke | M. Adams | Matthew Adams | Antoine Dara | Emily M. Stucke | Matthew Adams
[1] Zalak V. Shah,et al. Optimization of parasite DNA enrichment approaches to generate whole genome sequencing data for Plasmodium falciparum from low parasitaemia samples , 2019, Malaria Journal.
[2] M. Berriman,et al. Progression of the canonical reference malaria parasite genome from 2002–2019 , 2019, Wellcome open research.
[3] M. Berriman,et al. Progression of the canonical reference malaria parasite genome from 2002–2019 , 2019, Wellcome open research.
[4] A. Sette,et al. Comprehensive Review of Human Plasmodium falciparum-Specific CD8+ T Cell Epitopes , 2019, Front. Immunol..
[5] Joana C. Silva,et al. A Plasmodium berghei sporozoite-based vaccination platform against human malaria , 2018, npj Vaccines.
[6] D. Conway,et al. Long read assemblies of geographically dispersed Plasmodium falciparum isolates reveal highly structured subtelomeres , 2018, Wellcome open research.
[7] Alex B. Miller,et al. Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite , 2018, Nature Medicine.
[8] Julien Guizetti,et al. A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection , 2018, Cell reports.
[9] A. Vaughan,et al. A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice , 2018, Infection and Immunity.
[10] S. Hoffman,et al. A public antibody lineage that potently inhibits malaria infection by dual binding to the circumsporozoite protein , 2018, Nature Medicine.
[11] Daniel B. Roche,et al. Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia , 2017, Malaria Journal.
[12] M. Huynen,et al. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial , 2017, BMC Medicine.
[13] Joana C. Silva,et al. Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity , 2017, The Journal of infectious diseases.
[14] B. Mordmüller,et al. Life-span of in vitro differentiated Plasmodium falciparum gametocytes , 2017, Malaria Journal.
[15] Michael C. Schatz,et al. Accurate detection of complex structural variations using single molecule sequencing , 2017, Nature Methods.
[16] P. V. van Genderen,et al. Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers , 2017, Science Translational Medicine.
[17] Jonathan J. Juliano,et al. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia , 2017, Genome biology and evolution.
[18] D. Pratt,et al. Role of controlled human malaria infection (CHMI) in malaria vaccine development: A U.S. food & drug administration (FDA) perspective. , 2017, Vaccine.
[19] Erin E Gabriel,et al. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. , 2017, The Lancet. Infectious diseases.
[20] Joana C. Silva,et al. New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali , 2017, Genome Medicine.
[21] Sumana Chakravarty,et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine , 2017, Nature.
[22] Mario Roederer,et al. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection , 2017, Proceedings of the National Academy of Sciences.
[23] Samuel A. Assefa,et al. Culture adaptation of malaria parasites selects for convergent loss-of-function mutants , 2017, Scientific Reports.
[24] Sumana Chakravarty,et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. , 2017, JCI insight.
[25] Sergey Koren,et al. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation , 2016, bioRxiv.
[26] François Nosten,et al. Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance , 2016, bioRxiv.
[27] Michael C. Schatz,et al. Ribbon: Visualizing complex genome alignments and structural variation , 2016, bioRxiv.
[28] Michael C. Schatz,et al. Assemblytics: a web analytics tool for the detection of variants from an assembly , 2016, Bioinform..
[29] Gil McVean,et al. Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum , 2016, Genome research.
[30] R. Sinden,et al. Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions , 2016, Nature Protocols.
[31] Mihir Kekre,et al. Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification , 2016, Malaria Journal.
[32] M. Schatz,et al. Complete telomere-to-telomere de novo assembly of the Plasmodium falciparum genome through long-read (>11 kb), single molecule, real-time sequencing , 2016, DNA research : an international journal for rapid publication of reports on genes and genomes.
[33] V. Nene,et al. The biology of Theileria parva and control of East Coast fever - Current status and future trends. , 2016, Ticks and tick-borne diseases.
[34] Mario Roederer,et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination , 2016, Nature Medicine.
[35] M. Nielsen,et al. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets , 2016, Genome Medicine.
[36] Nicholas P. J. Day,et al. Genomic epidemiology of artemisinin resistant malaria. , 2016, eLife.
[37] E. Kamau,et al. The Genotypic and Phenotypic Stability of Plasmodium falciparum Field Isolates in Continuous In Vitro Culture , 2016, PloS one.
[38] Trevor Bedford,et al. Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. , 2015, The New England journal of medicine.
[39] Joana C. Silva,et al. The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence , 2015, BMC Genomics.
[40] U. Dalrymple,et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 , 2015, Nature.
[41] D. Wirth,et al. Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt , 2015, Proceedings of the National Academy of Sciences.
[42] Jacqueline A. Keane,et al. Circlator: automated circularization of genome assemblies using long sequencing reads , 2015, Genome Biology.
[43] G. van Gemert,et al. Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites , 2015, PloS one.
[44] John C. Tan,et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. , 2015, The Journal of infectious diseases.
[45] Andrew R. Jones,et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations , 2014, Nucleic Acids Res..
[46] Christina A. Cuomo,et al. Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement , 2014, PloS one.
[47] A. Barry,et al. Strategies for Designing and Monitoring Malaria Vaccines Targeting Diverse Antigens , 2014, Front. Immunol..
[48] Samuel A. Assefa,et al. A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains , 2014, Nature Communications.
[49] D. Kwiatkowski,et al. A transcriptional switch underlies commitment to sexual development in human malaria parasites , 2014, Nature.
[50] Manuel Llinás,et al. A transcriptional switch underlies commitment to sexual development in malaria parasites , 2014 .
[51] Mauricio O. Carneiro,et al. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.
[52] Mario Roederer,et al. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.
[53] Aaron A. Klammer,et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data , 2013, Nature Methods.
[54] Gilean McVean,et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia , 2013, Nature Genetics.
[55] K. Williamson,et al. Transposon mutagenesis identifies genes essential for Plasmodium falciparum gametocytogenesis , 2013, Proceedings of the National Academy of Sciences.
[56] O. Doumbo,et al. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. , 2013, The Journal of infectious diseases.
[57] Kristian E. Swearingen,et al. Total and Putative Surface Proteomics of Malaria Parasite Salivary Gland Sporozoites* , 2013, Molecular & Cellular Proteomics.
[58] S. Hoffman,et al. NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria Infections , 2012, The Journal of infectious diseases.
[59] S. Iwanaga,et al. Identification of an AP2-family Protein That Is Critical for Malaria Liver Stage Development , 2012, PloS one.
[60] Mauricio O. Carneiro,et al. Pacific biosciences sequencing technology for genotyping and variation discovery in human data , 2012, BMC Genomics.
[61] John C. Tan,et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing , 2012, Nature.
[62] Thomas S. Rask,et al. Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children , 2012, Proceedings of the National Academy of Sciences.
[63] Sergey I. Nikolenko,et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..
[64] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[65] F. Ayala,et al. Multiple independent introductions of Plasmodium falciparum in South America , 2011, Proceedings of the National Academy of Sciences.
[66] E. R. James,et al. Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity , 2011, Science.
[67] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[68] Sean R. Eddy,et al. Accelerated Profile HMM Searches , 2011, PLoS Comput. Biol..
[69] O. Doumbo,et al. A field trial to assess a blood-stage malaria vaccine. , 2011, The New England journal of medicine.
[70] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[71] Thomas S. Rask,et al. Plasmodium falciparum Erythrocyte Membrane Protein 1 Diversity in Seven Genomes – Divide and Conquer , 2010, PLoS Comput. Biol..
[72] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[73] May Ho,et al. Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs , 2010, Nature Genetics.
[74] Sumana Chakravarty,et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria , 2010, Human vaccines.
[75] C. Plowe,et al. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’ , 2009, Parasite immunology.
[76] David H. Alexander,et al. Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.
[77] C. Plowe. The evolution of drug-resistant malaria. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[78] M. Tanner,et al. First generation leishmaniasis vaccines: a review of field efficacy trials. , 2008, Vaccine.
[79] Martijn A. Huynen,et al. Proteomic Profiling of Plasmodium Sporozoite Maturation Identifies New Proteins Essential for Parasite Development and Infectivity , 2008, PLoS pathogens.
[80] Joseph D. Smith,et al. A family affair: var genes, PfEMP1 binding, and malaria disease. , 2006, Current opinion in microbiology.
[81] Thomas D. Wu,et al. GMAP: a genomic mapping and alignment program for mRNA and EST sequence , 2005, Bioinform..
[82] G Thomson,et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. , 2004, Tissue antigens.
[83] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[84] Ruben Abagyan,et al. Excess Polymorphisms in Genes for Membrane Proteins in Plasmodium falciparum , 2002, Science.
[85] Jonathan E. Allen,et al. Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.
[86] S. Meshnick,et al. Epidemiology of drug-resistant malaria. , 2002, The Lancet. Infectious diseases.
[87] S. Hoffman,et al. The Complexity of Protective Immunity Against Liver-Stage Malaria1 2 , 2000, The Journal of Immunology.
[88] S. Salzberg,et al. Alignment of whole genomes. , 1999, Nucleic acids research.
[89] K. Holmes,et al. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. , 1998, The Journal of infectious diseases.
[90] R. Armijos,et al. Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up. , 1998, The Journal of infectious diseases.
[91] J. García-Pacheco,et al. HLA class I and class II allele distribution in the Bubi population from the island of Bioko (Equatorial Guinea). , 1997, Tissue antigens.
[92] D. Conway,et al. Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate. , 1996, Molecular and biochemical parasitology.
[93] L. BenMohamed,et al. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. , 1994, Journal of immunology.
[94] D. Doolan,et al. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development , 1992, Infection and immunity.
[95] M. Good,et al. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[96] V. Nussenzweig,et al. γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.
[97] G. Langsley,et al. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning , 1987, Nature.
[98] T. Burkot,et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. , 1987, Science.
[99] D. Bj,et al. Tropical malaria contracted the natural way in the Netherlands , 1979 .
[100] B. Delemarre,et al. [Tropical malaria contracted the natural way in the Netherlands]. , 1979, Nederlands tijdschrift voor geneeskunde.
[101] W. Trager,et al. Human malaria parasites in continuous culture. , 1976, Science.